期刊文献+

骨髓增生异常综合征Cyr61和血管内皮细胞生长因子的表达及其相关性研究 被引量:2

Expression of cysteine rich 61 and vascular endothelial growth factor genes in patients with myelodys- plastic syndromes and their relationship
原文传递
导出
摘要 目的研究富半胱氨酸61(Cyr61)基因在骨髓增生异常综合征(MDS)不同亚型中的表达情况,探讨Cyr61基因在MDS发生、发展及向急性髓系白血病(AML)演变过程中的意义及其与血管内皮生长因子(VEGF)基因的关系。方法采用RT—PCR和免疫组化sP法对28例MDS患者、12例AML(其中包括4例由MDS转变而来)患者和10例对照者骨髓单个核细胞(BMMNC)中Cyr61和VEGFmRNA和蛋白质水平进行检测。结果Cyr61和VEGFmRNA在MDS组和AML组中的表达高于对照组,差异有统计学意义。Cyr61和VEGFmRNA在高危型MDS(RAEB—Ⅰ、RAEB一Ⅱ)(0.3998±0.2467,0.4775±0.1342)和AML患者中的表达(0.4594±0.1737,0.4967±0.2324)明显高于低危型MDS(RA、RARS、RCMD)患者中的表达(0.2213±0.1465,0.2872±0.2341)(P值均〈0.05)。高危型MDS患者Cyr61和VEGFmRNA的表达水平和AML患者相比差异无统计学意义。MDS患者Cyr61和VEGF蛋白的表达水平高于对照组,差异有统计学意义。高危型MDS患者Cyr61和VEGF蛋白的表达水平[(38.7±2.9)%,(43.2±2.7)%]明显高于低危型MDS患者[(31.4±3.1)%,(33.5±3.4)%](P〈0.05)。MDS患者Cyr61和VEGF的表达呈明显正相关关系(r=0.8762,P〈0.01)。结论Cyr61和VEGF可能在MDS骨髓血管生成及病情发展过程中发挥重要作用。 Objective To explore the expression of Cysleine-rich 61 ( Cyr61 ) gene in the different subtypes of myelodysplastic syndromes ( MDS), and the significance of Cyr61 in the genesis progression, and transformation of MDS and the relationship between Cyr61 and vascular endothelial grown factor (VEGF). Methods Reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemical S-P were used to detect mRNA and protein expressions of Cyr61 and VEGF in bone marrow mononuclear cells (BMMNC) from 28 MDS, 12 acute myeloid leukemia(AML) patients, and 10 normal volunteers. Results Expressions of Cyr61 and VEGF were higher in MDS and AML patients than in controls(P 〈0.05). The expressions of Cyr61 and VEGF were significantly higher in high risk group ( 0. 3998 ± 0. 2647,0. 4775 ±0. 1342) than that in low risk MDS group(0. 2213 ±0. 1465, 0. 2872±0. 2341 ) (P 〈0.05), but no significant difference between high risk MDS and AML patients. Expressions of Cyr61 and VEGF protein were high- er in MDS patients than in normal controls( P 〈 0.05 ), and were significantly higher in high risk MDS group [(38.7±2.9)%,(43.2_+2.7)%] than in low risk group [(31.4 ±3.1)%, (33.5 ±3.4)%l(p〈 0.05). Expressions of Cyr61 and VEGF were significantly correlated( r =0. 8762, P 〈0.01 ). Condusion Cyr61 and VEGF may play a role in the angiogenesis and pathogenesis of MDS.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2009年第11期745-748,共4页 Chinese Journal of Hematology
关键词 骨髓增生异常综合征 富半胱氨酸61 血管内皮生长因子 聚合酶链反应 Myelodysplastie syndromes Cysteine-rieh 61 Vascular endothelial growth factor Reverse transcriptase-polymerase chain reaction
  • 相关文献

参考文献11

  • 1Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 2000,96:2240 - 2245. 被引量:1
  • 2Xie D,Yin D,Wang HJ,et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res,2004,10:2072-2081. 被引量:1
  • 3张之南,沈悌主编..血液病诊断及疗效标准 第3版[M].北京:科学出版社,2007:271.
  • 4Chen CC, Chen N, Lau LF. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling inprimary human skin fibroblasts. Biol Chem ,2001,276 : 10443-10452. 被引量:1
  • 5Jay P, Berge-Lefranc JL, Marsollier C, et al. The human growth factor-inducible immediate early gene. CYR61, maps to Chromosome lp. Oncogene, 1997,14 : 1753-1757. 被引量:1
  • 6O' Brien TP, Lau LF. Expression of the growth factor inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Difer, 1992,3:645- 654. 被引量:1
  • 7Walker TM, van Ginkel PR, Gee RL, et al. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol,2002,120 : 1719-1725. 被引量:1
  • 8Tsai MS, Bogart DF, Castaneda JM, et al. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 2002, 21 : 8178- 8185. 被引量:1
  • 9Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of Cyi61 ( CCN1 ) mediated through integrins alphavbeta3 and alpha6betal in human umbilical vein endothelial cells. J Biol Chem, 2002, 277:46248--46255. 被引量:1
  • 10Tsai MS, Bogart DF, Li P, et al. Expression and regulation of Cyr61 in human breast cancer cell lines. Oncogene, 2002,21: 964 -973. 被引量:1

同被引文献27

  • 1贺其图,赵晓华,贾国荣,马宏杰,李静,李喆,刘学文,云雁.白血病患者骨髓血管新生与Bcl-2蛋白关系的研究[J].实用癌症杂志,2006,21(4):376-378. 被引量:9
  • 2Brigstock DR. The connective tissue growth factor/cysteine- rich 61/nephroblastoma overexpressed (CCN) family[J]. En- docr Rev,1999,20(2) :189-206. 被引量:1
  • 3Kireeva ML, MO FE, Yang GP, et al. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion [J]. Mol Cell Biol, 1996,16(4) : 1326-34. 被引量:1
  • 4Hashimoto G, Inoki I, Fujii Y, et al. Matrix metalloprotein- ases cleave connective tissue growth factor and reactivate an- giogenic activity of vascular endothelial growth factor 165[J]. Biol Chem,2002,277(39) :36288-95. 被引量:1
  • 5Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins[J]. Int J Biochem Cell Biol, 2009,41 (4) :771-83. 被引量:1
  • 6Menfindez JA, Mehmi I, Griggs DW, et al. The angiogenic factor CYR61 in breast cancer: molecular pathology and ther- apeutic perspectives[J]. Endocr Relat Cancer, 2003,10 (2) : 141-52. 被引量:1
  • 7Aikawa T, Gunn J, Spong SM, et al. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer[J]. Mol Cancer Ther, 2006,5(5) : 1108-16. 被引量:1
  • 8Kang Y, Siegel PM, Shu W, et al. A multigenic program me- diating breast cancer metastasis to bone [J]. Cancer Cell, 2003,3(6) :537-49. 被引量:1
  • 9Shimo T, Kubota S, Yoshioka N, et al. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer[J]. Bone Miner Res, 2006,21(7) : 1045-59. 被引量:1
  • 10Tong X, Xie D, O'Kelly J,et al. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer [J]. Biol Chem,2001,276(50) :47709-14. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部